The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older
Abstract
Although the individual components of the metabolic syndrome are clearly associated with increased risk for coronary heart disease (CHD), we wanted to quantify the increased prevalence of CHD among people with metabolic syndrome. The Third National Health and Nutrition Examination Survey (NHANES III) was used to categorize adults over 50 years of age by presence of metabolic syndrome (National Cholesterol Education Program [NCEP] definition) with or without diabetes. Demographic and risk factor information was determined for each group, as well as the proportion of each group meeting specific criteria for metabolic syndrome. The prevalence of CHD for each group was then determined. Metabolic syndrome is very common, with ∼44% of the U.S. population over 50 years of age meeting the NCEP criteria. In contrast, diabetes without metabolic syndrome is uncommon (13% of those with diabetes). Older Americans over 50 years of age without metabolic syndrome regardless of diabetes status had the lowest CHD prevalence (8.7% without diabetes, 7.5% with diabetes). Compared with those with metabolic syndrome, people with diabetes without metabolic syndrome did not have an increase in CHD prevalence. Those with metabolic syndrome without diabetes had higher CHD prevalence (13.9%), and those with both metabolic syndrome and diabetes had the highest prevalence of CHD (19.2%) compared with those with neither. Metabolic syndrome was a significant univariate predictor of prevalent CHD (OR 2.07, 95% CI 1.66–2.59). However, blood pressure, HDL cholesterol, and diabetes, but not presence of metabolic syndrome, were significant multivariate predictors of prevalent CHD. The prevalence of CHD markedly increased with the presence of metabolic syndrome. Among people with diabetes, the prevalence of metabolic syndrome was very high, and those with diabetes and metabolic syndrome had the highest prevalence of CHD. Among all individuals with diabetes, prevalence of CHD was increased compared with those with metabolic syndrome without diabetes. However, individuals with diabetes without metabolic syndrome had no greater prevalence of CHD compared with those with neither.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In individuals with diabetes, the coexistence of other metabolic syndrome factors denotes a higher risk for future development of ASCVD.69”
From Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (2005) · cites this paper as [69]
In the citing paper
“the combination of MS and hypertension has been reported to result in an even higher morbidity and mortality.11”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [11]
In the citing paper
“It is already known that MS or EHT patients have a high cardiovascular risk”
From Sympathetic Neural Activation in Nondiabetic Metabolic Syndrome and Its Further Augmentation by Hypertension (2004) · cites this paper as [11]
In the citing paper
“ASCVD risk is higher with MetS in the absence of T2D compared with T2D without MetS (13.9% vs. 7.5%, respectively) (13).”
From The CardioMetabolic Health Alliance (2015) · cites this paper as [13]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Cardiovascular Survey Methods.
Rose, G., & Blackburn, H. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,090
Cited by
Sorted by citations
Items 901–998 of 998
Distinct Predictors and Comorbidities in Early Onset Type 2 Diabetes Mellitus Among Asian Indians
Vijayakumar, G., Sreehari, G., Vijayakumar, A., & Jaleel, A. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0047 · Cited by 10
Argentati, C., Tortorella, I., Bazzucchi, M., Emiliani, C., Morena, F., & Martino, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030115 · Cited by 10
[ENPP1 K121Q polymorphism and ischemic heart disease in diabetic patients].
Moehlecke, M., Kramer, C. K., Leitão, C. B., Krahe, A. L., Balbosco, I., de Azevedo, M. J., Gross, J. L., & Canani, L. H. S. (2010) · PubMed · doi:10.1590/s0066-782x2010000200005 · Cited by 9
The Endocannabinoid System as a Target for Obesity Treatment
Aronne, L. J., Pagotto, U., Foster, G. D., & Davis, S. N. (2008) · Clinical cornerstone · doi:10.1016/s1098-3597(08)60028-9 · Cited by 9
Wild, S. H., & Byrne, C. D. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.1424-5.x · Cited by 9
Prevalence of metabolic syndrome among Psychiatric Patients in the Kumasi Metropolis, Ghana
Owiredu, W. K. B. A., Osei, O., Amidu, N., Appiah‐Poku, J., & Osei, Y. (2012) · Journal of Medical and Biomedical Sciences · Cited by 9
Hur, S., Won, K., Kim, I., Bae, J., Choi, D., Ahn, Y., Park, J., Kim, H.-S., Choi, R. K., Choi, D., et al. (2016) · Medicine · doi:10.1097/md.0000000000003882 · Cited by 9
Cranston, M. M., True, M. W., Wardian, J., Carriere, R., & Sauerwein, T. J. (2017) · Military Medicine · doi:10.7205/milmed-d-16-00253 · Cited by 9
Shara, N. M., Zeymo, A., Abudiab, Z., Umans, J. G., Abu-Bader, S. H., Getaneh, A., & Howard, B. V. (2017) · Journal of Immigrant and Minority Health · doi:10.1007/s10903-017-0626-0 · Cited by 9
The Metabolic Syndrome and Cerebrovascular Disease: Suspicion and Evidence
Gil-Núñez, A. (2007) · Cerebrovascular Diseases · doi:10.1159/000107380 · Cited by 9
“], although some studies have shown that the MS does not pose a risk greater than the sum of its component parts [ ,”
Background2nd International Symposium on Triglycerides and HDL
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2577 · Cited by 9
“Similarly, there is CVD risk associated with metabolic syndrome (4), with some investigators finding residual risk after taking into account all the specific components (38), while others report that the presence of metabolic syndrome itself loses significance after factoring out the specific components of HDL cholest…”
BackgroundNeligan, P. J., & Fleisher, L. A. (2006) · Anesthesiology · doi:10.1097/00000542-200603000-00003 · Cited by 9
Bedeutung von Adipositas und Bewegungsmangel in der kardiovaskulären Primärprävention
König, D., Bönner, G., & Berg, A. (2007) · Herz · doi:10.1007/s00059-007-3019-7 · Cited by 9
Management of metabolic syndrome: statins
Xydakis, A. M., & Ballantyne, C. M. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.011 · Cited by 9
Metabolic syndrome, inflammation, and exercise
Lavie, C. J., & Milani, R. V. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.018 · Cited by 9
Nuevas estrategias en prevención cardiovascular
Cordero, A., Alegría‐Barrero, E., Moreno, J., Fernández, E., & Saénz, J. D. (2017) · Revista de medicina de la Universidad de Navarra · doi:10.15581/021.7545 · Cited by 9
Tang, K., Zhang, Q., Peng, N., Zhang, M., Xu, S., Li, H., Hu, Y., Xue, C., Shi, L., & the REACTION Study Group (2020) · Journal of International Medical Research · doi:10.1177/0300060520966878 · Cited by 8
Magalhães, P. M., Teixeira, J. E., Bragada, J. P., Duarte, C. M., & Bragada, J. A. A. (2023) · Healthcare · doi:10.3390/healthcare11121712 · Cited by 8
“Obesity is increasing worldwide and is one of the main causes of type 2 diabetes (T2D), which is a chronic metabolic disease with a growing impact on morbidity and mortality [1,2].”
BackgroundRago, L., Castelnuovo, A. F. D., Assanelli, D., Badilini, F., Vaglio, M., Gianfagna, F., Salvetti, M., Zito, F., Alessandrini, F., Donati, M. B., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.010 · Cited by 8
Dentali, F., Squizzato, A., Caprioli, M., Fiore, V., Bernasconi, M., Paganini, E. M., Ageno, W., Venco, A., & Grandi, A. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2010.12.006 · Cited by 8
Evaluación del riesgo cardiovascular e intervención en los pacientes con VIH
Hernández, S., Vidal, M., & Pedrol, E. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(09)73444-5 · Cited by 9
Osman, M. T., Rahman, T. H. A., Ismail, T. S. T., Azlina, A. R., & Nawawi, H. M. (2016) · International Archives of Medicine · doi:10.3823/1879 · Cited by 8
“Results of the prospective Québec Cardiovascular Study have revealed that the presence of some features of MS found in viscerally obese men was predictive of a substantially increased risk of coronary heart disease (CHD) [26].”
BackgroundCardiovascular Risk Factors and Ischemic Heart Disease
Elosúa, R., Lluís-Ganella, C., Subirana, I., Havulinna, A. S., Läll, K., Lucas, G., Sayols-Baixeras, S., Pietilä, A., Alver, M., de León, A. C., et al. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001255 · Cited by 8
Yang, Y. J., Park, H.-J., Won, K., Chang, H., Park, G., Kim, Y., Ann, S. H., Park, E. J., Kim, S., & Lee, S. G. (2019) · Medicine · doi:10.1097/md.0000000000017620 · Cited by 8
Oğuz, A. (2020) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2020.27227 · Cited by 11
Zhu, X., Chen, Z., Yang, P., Liu, L., Wu, L., & Wang, Y. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.07.007 · Cited by 8
Delautre, A., Chantrel, F., Dimitrov, Y., Klein, A., Imhoff, O., Muller, C., Schauder, N., Hannedouche, T., & Krummel, T. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02004-3 · Cited by 9
Colpitts, B. H., Smith, S., B̀ouchard, D. R., Boudreau, J. G., & Sénéchal, M. (2020) · Translational Sports Medicine · doi:10.1002/tsm2.216 · Cited by 8
Xu, J., Song, Y., Jiang, P. X., Jiang, L., Zhao, X.-Y., Gao, Z., Li, J., Qiao, S., Gao, R.-L., Yang, Y., et al. (2020) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2021.01.006 · Cited by 8
Utility of metabolic syndrome as a risk enhancing factor in decision of statin use
Vega, G. L., Wang, J., & Grundy, S. M. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.01.012 · Cited by 8
The health promotion lifestyle of metabolic syndrome individuals with a diet and exercise programme
Lin, Y., & Chu, L. (2013) · International Journal of Nursing Practice · doi:10.1111/ijn.12149 · Cited by 8
The metabolic syndrome: evolving evidence that thiazolidinediones provide rational therapy
Wyne, K. L. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00522.x · Cited by 8
Managing Multiple Cardiovascular Risk Factors: State of the Science
Levine, J. H. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.05924.x · Cited by 8
Impaired glucose metabolism in hypertensive patients with/without the metabolic syndrome
Schianca, G. P. C., Fra, G. P., Steffanini, M., Pogliani, G., Marconi, C., Bigliocca, M., & Pirisi, M. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.04.006 · Cited by 8
“It has been reported in fact that Mets alone have a higher CV risk, but to a lesser degree than those with Mets coupled to diabetes [28].”
BackgroundDebin, R., Lauzier, B., Sicard, P., Delemasure, S., Amoureux, S., Duvillard, L., Vergely, C., Cottin, Y., & Rochette, L. (2009) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00659.x · Cited by 8
Risk factors clustering within the metabolic syndrome: a pattern or by chance?
Parapid, B. J., Ostojić, M., Lalic, N. M., Micić, D., Damjanovic, S. S., Bubanja, D., Simic, D. V., Lalic, K. S., Polovina, S. P., Marinković, J., et al. (2014) · PubMed · Cited by 9
Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits.
Hatef-Fard, M. R., Khodabandeh, M., Sahebari, M., Ghayour‐Mobarhan, M., & Rezaieyazdi, Z. (2016) · PubMed Central · Cited by 8
Liu, Z., Zhou, Z., Huang, G., Xiao, Y., Li, Z., Liu, C., & Na, R. (2016) · Medicine · doi:10.1097/md.0000000000005201 · Cited by 8
Huang, Y., Gu, L., Li, N., Fang, F., Ding, X., Wang, Y., & Peng, Y. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00653-4 · Cited by 9
Waist Circumference and Metabolic Syndrome: The Risk for Silent Coronary Artery Disease in Males
Vakil, K. P., Malhotra, S., Sawada, S. G., Campbell, S., Sayfo, S., & Kamalesh, M. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0099 · Cited by 8
Screening and risk stratification of patients with the metabolic syndrome and diabetes
Wong, N. D. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.2.181 · Cited by 8
Wong, N. D., Gransar, H., Shaw, L. J., Polk, D. M., & Berman, D. S. (2006) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2006.05618.x · Cited by 8
The Association between Midnight Salivary Cortisol and Metabolic Syndrome in Korean Adults
Jang, Y.-M., Lee, E. J., Kim, D. L., Kim, S. K., & Song, K. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.3.245 · Cited by 8
Le syndrome métabolique : quelle(s) définition(s) pour quel(s) objectif(s) ?
Eschwège, É. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81732-9 · Cited by 13
“On comprend donc aisément l’intérêt en termes de santé publique de tels programmes d’évaluation et du caractère prédictif des analyses et conclusions qui en résultent, surtout dès lors que l’on extrapole ces données aux 76,1 millions d’Américains de cette tranche d’âge, soit 11 263 000 individus avec diabète et syndro…”
BackgroundInfluentialIs the metabolic syndrome a real clinical entity and should it receive drug treatment?
Darsow, T., Kendall, D. M., & Maggs, D. G. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0006-y · Cited by 8
“Although microvascular and premature macrovascular disease are observed in both type 1 and type 2 diabetes, features of metabolic syndrome are most prevalent (up to 85%) in patients with type 2 diabetes [ 7 ].”
BackgroundThe interplay of cardiovascular risk factors in the metabolic syndrome and type 2 diabetes
Betteridge, D. J. (2004) · European Heart Journal Supplements · doi:10.1016/j.ehjsup.2004.10.002 · Cited by 8
Parámetros antropométricos asociados al riesgo cardiovascular en España. Estudio DORICA
Millán, J., Mantilla, T., Bartrina, J. A., Foz, M., Gil, B., Jover, E., Monereo, S., Moreno, B., & Pérez, C. (2007) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(07)74175-x · Cited by 8
[The metabolic syndrome: a cluster of vascular risk factors].
Olijhoek, J. K., Martens, F. M. A. C., Banga, J. D., & Visseren, F. L. J. (2005) · PubMed · Cited by 8
High prevalence of risk factors for physical illness in a long-stay psychiatric unit
O’Brien, S., Devitt, E., Ahmed, M. R., & McDonald, C. (2007) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700010223 · Cited by 8
Epidemiología del síndrome metabólico y diabetes mellitus tipo 2: ¿El diluvio que viene?
Trejo-Gutiérrez, J. F. (2004) · Revista Portuguesa de Pneumologia · Cited by 8
Inflammation and Metabolic Syndrome
Devaraj, S., Siegel, D., & Jialal, I. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch13 · Cited by 8
Criteria for diagnosing the metabolic syndrome
Oda, E. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.5.1251 · Cited by 8
“However, neither abdominal obesity nor the metabolic syndrome, defined on the basis of the National Cholesterol Education Program Adult Treatment Panel III (NCEP-ATPIII) criteria, was shown to be a significant independent risk factor for CVD in multiple regression analyses (4, 5).”
BackgroundThe metabolic syndrome, inflammation and cardiovascular disease in type 2 diabetes
Roberts, A. W., & Evans, M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200402000-00016 · Cited by 8
Does the Metabolic Syndrome Exist
Davidson, M. B. (2006) · Diabetes Care · doi:10.2337/dc06-1592 · Cited by 8
Metabolic syndrome in dyslipidemia consultations.
Monteiro, S. R., Dias, P., Madeira, S. G., de Moura, P., Silva, J. M., Providência, L. A., & de Moura, J. J. A. (2006) · PubMed · Cited by 7
Gumanova, N. G. (2019) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2019-5-117-127 · Cited by 7
Synthesis of novel quinazolinone-triheterocyclic hybrides as dual inhibition of urease and ache
Menteşe, E., Güzel, Y. Ü., Akyüz, G., & Karaali, N. (2024) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-024-03080-0 · Cited by 7
Prevalence of the Metabolic Syndrome in the Yan-an Region of Northwest China
Li, S.-L., Yang, Q., Lv, S.-Y., Zhang, Y., & Zhang, J.-A. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000230 · Cited by 7
Davies, M. (2014) · International Journal of TROPICAL DISEASE & Health · doi:10.9734/ijtdh/2014/5864 · Cited by 7
Moon, H., Lee, Y., Kim, S., Kim, D. K., Chin, H. J., Joo, K. W., Kim, Y. S., Na, K. Y., & Han, S. S. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e312 · Cited by 7
Sengupta, J., Das, H., Chellaiyan, V. G., Sasithra, S., & Jennifer Britto, J. (2022) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2022.101010 · Cited by 7
Gosalia, J., Montgomery, P. S., Zhang, S., Pomilla, W. A., Wang, M., Liang, M., Csiszár, A., Ungvari, Z. I., Yabluchanskiy, A., Proctor, D. N., et al. (2022) · GeroScience · doi:10.1007/s11357-022-00640-1 · Cited by 7
Diagnóstico de síndrome metabólico. Adecuación de los criterios diagnósticos en nuestro medio
Ascaso, J. F., González‐Santos, P., Hernández‐Mijares, A., Mangas, A., Masana, L., Millán, J., Pallardo, L. F., Pedro‐Botet, J., Pérez‐Jiménez, F., Pintó, X., et al. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73697-x · Cited by 9
Li, H., Deng, X., Li, Z., Luo, C., Liu, J., & Wang, Y. (2011) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-011-0373-8 · Cited by 7
Schmolling, Y., del Valle, F. D., de Oteyza, C. P. D., de Lucas, A. D., Brasero, F., & Fajardo, F. (2008) · Revista Clínica Española · doi:10.1157/13117038 · Cited by 8
Composition of Metabolic Syndrome Among Korean Adults in a Lifestyle Modification Intervention
Yoon, N., Yoo, S., & Kim, H. (2014) · Osong Public Health and Research Perspectives · doi:10.1016/j.phrp.2014.10.005 · Cited by 7
Prevalence of the metabolic syndrome and its relationship with diabetes mellitus by aging
Kawada, T., Otsuka, T., Endo, T., & Kon, Y. (2011) · The Aging Male · doi:10.3109/13685538.2011.565092 · Cited by 7
Ashen, M. D. (2008) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2008.07.018 · Cited by 7
Therapeutic interventions for hypertension in metabolic syndrome: a comprehensive approach
Ganne, S., Arora, S., Karam, J. G., & McFarlane, S. I. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.2.201 · Cited by 7
Rational Antipsychotic Choice: Weighing the Risk of Tardive Dyskinesia and Metabolic Syndrome
Stoklosa, J., & Öngür, D. (2011) · Harvard Review of Psychiatry · doi:10.3109/10673229.2011.614100 · Cited by 7
Cynical hostility and the metabolic syndrome: A case-control study
Gremigni, P. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2006.524 · Cited by 7
“Metabolic syndrome. The metabolic syndrome was defined as having >2 of the following physiologic risk factors: BMI (weight in kilograms divided by height in meters squared) >27, used as an index of obesity in other large epidemiological studies [17, 24 ]; abnormal glucose metabolism, measured during the preprandial st…”
MethodDing, Z., Pi, F., Zhang, S., Dong, W., Wen, Y., Wu, J., & Zhang, Q. (2016) · Scientific Reports · doi:10.1038/srep22210 · Cited by 7
Glycemic control in diabetes with metabolic syndrome in community hospital.
Worawongprapa, O. (2008) · PubMed · Cited by 7
Mosharraf, S., Sharifzadeh, G., Darvishzadeh-Boroujeni, P., & Rouhi-Boroujeni, H. (2013) · Europe PMC (PubMed Central) · Cited by 7
Panzer, C., Brieke, A., & Ruderman, N. B. (2003) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/00060793-200308000-00001 · Cited by 7
Bermúdez, J., Finol, J. G. F., Leal, N., Parra, G. V. M., Peñaranda, P. M. L., Pérez, C., Vílchez, D., Núñez, M., Linares, S., Amell, A., et al. (2009) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 6
Importancia del síndrome metabólico y de su definición dependiendo de los criterios utilizados
Real, J. T., & Carmena, R. (2005) · Medicina Clínica · doi:10.1157/13072572 · Cited by 9
The metabolic syndrome: ‘To be or not to be, that is the question
Grant, P. J., & McGuire, D. K. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.1930_5.x · Cited by 7
Avramoglu, R. K., Laplante, M., Quang, K. L., Deshaies, Y., Després, J., Larose, É., Mathieu, P., Poirier, P., Përusse, L., Vohl, M., et al. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.08.262 · Cited by 7
“In addition to the effects of smoking, blood pressure and cholesterol levels on CVD risk in T2D patients, there is accumulating evidence that a subgroup of T2D patients with a high triglyceridedlow HDL-cholesterol dyslipidemia are at greater risk of CVD than T2D patients matched for the same hyperglycemic state, but w…”
BackgroundHeppenstall, C., Bunce, S., & Smith, J. C. (2012) · Nutrition Journal · doi:10.1186/1475-2891-11-50 · Cited by 7
“The aim of this study was as follows:- [1] to assess weight and metabolic changes following rimonabant therapy in obese patients with type 2 diabetes; [2] to investigate in detail, changes in energy, macro- and micronutrient intake following rimonabant therapy; and [3] to investigate how changes in macronutrient intak…”
BackgroundMethodRuderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 7
Lester, J. W., & Fernandes, A. W. (2005) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2005.00459.x · Cited by 7
Shape of the Nations survey and attitudes to cardiometabolic risk
Wierzbicki, A. S., Ganotakis, E. S., & Mikhailidis, D. P. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x162638 · Cited by 7
Irie, H., Shiraishi, J., Sawada, T., Koide, M., Yamada, H., & Matsubara, H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.06.103 · Cited by 7
RetractedYun, K. W., Kim, B. H., Bae, Y. P., Yi, B. D., Lee, S., Lim, H. K., Ryu, Y. S., & Lee, C. W. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.4.346 · Cited by 6
Sonenberg, A., Knepper, H. J., & Pulcini, J. A. (2015) · Poverty & Public Policy · doi:10.1002/pop4.119 · Cited by 6
Zoellner, J., & Porter, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00006-0 · Cited by 5
Yang, W., Guo, S., Wang, H., Li, Y., Zhang, X., Hu, Y., Guo, H., Wang, K., Yan, Y., Zhang, J., et al. (2021) · BMC Public Health · doi:10.1186/s12889-021-10241-w · Cited by 6
Mulindwa, F., Kamal, H., Castelnuovo, B., Bollinger, R. C., Schwarz, J., & Brussealers, N. (2022) · PLoS ONE · doi:10.1371/journal.pone.0264792 · Cited by 6
Echevarría-Castro, N., Silva-Parra, K. A., Polar-Trinidad, M., Sánchez-Vicente, J. C., Salinas-Sedo, G., & Toro-Huamanchumo, C. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164692 · Cited by 6
“Some related diseases include coronary heart disease, type 2 diabetes mellitus (T2DM), polycystic ovary syndrome, nonalcoholic fatty liver (NAFLD), asthma, sleep disorders and some types of cancer [3,4].”
BackgroundEffect of a Weight Management Program on the Determinants and Prevalence of Metabolic Syndrome
Londe, M. L., Graffagnino, C. L., Falko, J. M., Snow, R. J., Spencer, K., & Caulin‐Glaser, T. (2008) · Obesity · doi:10.1038/oby.2007.86 · Cited by 7
“5% of US adults ≥50 years having met synd (10).”
BackgroundRole of hypertension in the metabolic syndrome: Who is affected?
Velarde, G., & Berk, B. C. (2005) · Current Hypertension Reports · doi:10.1007/s11906-005-0036-x · Cited by 9
“The prevalence rose steeply after the third decade in both men and women and reached a peak in men aged 50 to 70 and in women aged 60 to 80 [ 4 ].”
BackgroundKamalesh, M., Campbell, S., Ligler, L., Meda, M., Eckert, G. J., & Sawada, S. G. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0079 · Cited by 6
Factores de riesgo del síndrome metabólico en la muerte súbita cardíaca
Montes, L. A. O., Medina, C. A. Y., Bouza, R. O. C., Lugo, M. G., Nodarse, R. M., Izquierdo, E. V., & Londres, H. D. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 6
Khademvatani, K., Alinejad, V., Eghtedar, S., Rahbar, N., & Aghakhani, N. (2014) · Global Journal of Health Science · doi:10.5539/gjhs.v6n7p58 · Cited by 6
“In another study, LDL level in patients with coronary heart attack was 2.2 times more than healthy people (Alexander et al., 2003).”
BackgroundInfluentialCañón-Barroso, L., Herrera, N. D., Hueros, J. I. C., Muro, E. C., Hernández, T. N., & Buitrago, F. (2007) · Medicina Clínica · doi:10.1157/13101162 · Cited by 6
Incidence of myocardial infarction in low-income urban residents of Mexico City
Jiménez-Corona, A., López‐Ridaura, R., & González‐Villalpando, C. (2009) · Salud Pública de México · doi:10.1590/s0036-36342009000600003 · Cited by 6
(2004) · PubMed · Cited by 108
Metadata
- Authors
- Alexander, C. M., Landsman, P. B., Teutsch, S. M., & Haffner, S. M.
- Affiliations
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- The University of Texas at San Antonio Health Science Center (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2003-05-01
- Volume
- 52
- Issue
- 5
- Pages
- 1210-1214
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2151152924
- Cited by
- 1,475
- References
- 30
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 18 · 2023: 20 · 2022: 30 · 2021: 37 · 2020: 32 · 2019: 30 · 2018: 42 · 2017: 39 · 2016: 51 · 2015: 43 · 2014: 61 · 2013: 65 · 2012: 73
- FWCI
- 77.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- metabolic syndrome, coronary artery disease, prevalence, older adults, NCEP criteria, NHANES III, cardiovascular risk factors, blood pressure, HDL cholesterol
- MeSH terms
- Age Factors, Blood Pressure, Body Constitution, Coronary Disease, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Female, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Patient Education as Topic, Physical Examination, Surveys and Questionnaires, Risk Factors, Smoking, United States, Prevalence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
